EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging therapeutic paradigms in tuberculosis: Nanocarriers, host-directed strategies, and translational pharmacology

Anjali Saxena, Summer Bhagra, Shuvayoo Das, Naveen Kaushik, Biswajit Saha

Microbial Pathogenesis · 2026

DOI: 10.1016/j.micpath.2026.108545 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2026. Verfasst von Anjali Saxena und 4 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Tuberculosis, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 241 Literaturangaben. Gefördert von: Alexander von Humboldt Foundation, Amity Institute of Biotechnology, Amity University, Amity University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntitubercular AgentsTuberculosisNanoparticlesDrug CarriersHumansHost-Directed TherapyDrug Delivery SystemsMacrophagesAnimals

Stichwörter der Autor:innen

Conventional therapiesHDTLiposomesNanocapsulesNanocarrierNanomedicineNiosomesTuberculosis

Substanzen

Antitubercular AgentsDrug Carriers

Autor:innen und Institutionen

  • Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India.
  • Department of Industrial Biotechnology, College of Biotechnology, CCS Haryana Agricultural University, Hisar, (Haryana), India.
  • Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India. Electronic address: biswasaha@gmail.com.

Förderung

  • Alexander von Humboldt Foundation
  • Amity Institute of Biotechnology, Amity University
  • Amity University

Zitieren

APA

Saxena, A., Bhagra, S., Das, S., Kaushik, N., & Saha, B. (2026). Emerging therapeutic paradigms in tuberculosis: Nanocarriers, host-directed strategies, and translational pharmacology. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2026.108545

Vancouver

Saxena A, Bhagra S, Das S, Kaushik N, Saha B. Emerging therapeutic paradigms in tuberculosis: Nanocarriers, host-directed strategies, and translational pharmacology. Microbial Pathogenesis. 2026. doi:10.1016/j.micpath.2026.108545

BibTeX
@article{Saxena2026,
  author = {Saxena, Anjali and Bhagra, Summer and Das, Shuvayoo and Kaushik, Naveen and Saha, Biswajit},
  title = {Emerging therapeutic paradigms in tuberculosis: Nanocarriers, host-directed strategies, and translational pharmacology},
  journal = {Microbial Pathogenesis},
  year = {2026},
  doi = {10.1016/j.micpath.2026.108545}
}
Kostenlos starten →